TABLE 1.
Target gene | Primer sequence (5′to 3′) | Size (bp) | ||
---|---|---|---|---|
Name | Id | Forward | Reverse | |
ACSL4 | 2,182 | ATACCTGGACTGGGACCGAA | TGCTGGACTGGTCAGAGAGT | 145 |
TfR1 | 7,037 | TGGAGACTTTGGATCGGTTGGTG | CAGTGGCTGGCAGAAACCTTG | 138 |
NCOA4 | 8031 | GGGCAACCTCAGCCAGTTAT | CAAACTGCAGGGAGGCCATA | 139 |
FTH1 | 2,495 | CCAGAACTACCACCAGGACTC | CAAAGCCACATCATCGCGG | 118 |
GPX4 | 2,879 | CAGTGAGGCAAGACCGAAGT | CCGAACTGGTTACACGGGAA | 104 |
xCT | 23657 | CATCTCTCCTAAGGGCGTGC | TAGTGACAGGACCCCACACA | 85 |
H O -1 | 3162 | CCGCATGAACTCCCTGGAGATG | CTGGATGTTGAGCAGGAACGCAG | 85 |
β-actin | 60 | CCTGGCACCCAGCACAAT | GGGCCGGACTCGTCATAC | 114 |
ACSL4: acyl-CoA, synthetase long-chain family member 4; NCOA4: nuclear receptor coactivator 4; FTH1: ferritin heavy chain 1; GPX4: glutathione peroxidase 4; H O -1: heme oxygenase 1; xCT: cystine-glutamate antiporter; TfR1: transferrin receptor 1.